EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Does TNF Promote or Restrain Osteoclastogenesis and Inflammatory Bone Resorption?

Baohong Zhao

Critical Reviews in Immunology · 2018 · 38 (4) · 253-261

DOI: 10.1615/critrevimmunol.2018025874 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Critical Reviews in Immunology, 2018. Verfasst von Baohong Zhao. Beteiligte Einrichtung: Arthritis and Tissue Degeneration Program and David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, Graduate Program in Biochem…. Die Arbeit wurde bisher 30-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic inflammation is one of the most evident and common pathological conditions leading to deregulated osteoclastogenesis and bone remodeling. Tumor necrosis factor (TNF) as a pleiotropic cytokine plays a key role, not only in inflammation, but also in bone erosion in diseases associated with bone loss. TNF can stimulate the proliferation of osteoclast precursors and, in most conditions, act together with other cytokines and growth factors such as receptor activator of nuclear factor (NF)-[kappa]B ligand (RANKL), interleukin-6, and transforming growth factor beta to synergistically promote osteoclast formation and bone resorption in vivo. A longstanding enigma in the field is why TNF alone is not able to induce osteoclast differentiation as effectively as the same superfamily member RANKL, a physiological master osteoclastogenic cytokine. Recent studies have highlighted several lines of evidence showing the intrinsic mechanisms through RBP-J, NF-[kappa]B p100/TNF receptor-associated factor 3, or interferon regulatory factor-8 that restrain TNF-induced osteoclast differentiation and bone resorption. These feedback inhibitory mechanisms driven by TNF shed light into the current paradigm of osteoclastogenesis and would provide novel therapeutic implications on controlling inflammatory bone resorption.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsBone ResorptionHumansInflammationOsteogenesisTumor Necrosis Factors

Substanzen

Tumor Necrosis Factors

Autor:innen und Institutionen

  • Arthritis and Tissue Degeneration Program and David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, Graduate Program in Biochemistry, Cell and Molecular Biology, Weill Cornell Graduate School of Me…

Förderung

  • NIAMS NIH HHS

Zitieren

APA

Zhao, B. (2018). Does TNF Promote or Restrain Osteoclastogenesis and Inflammatory Bone Resorption?. Critical Reviews in Immunology, 38(4), 253-261. https://doi.org/10.1615/critrevimmunol.2018025874

Vancouver

Zhao B. Does TNF Promote or Restrain Osteoclastogenesis and Inflammatory Bone Resorption?. Critical Reviews in Immunology. 2018;38(4):253-261. doi:10.1615/critrevimmunol.2018025874

BibTeX
@article{Zhao2018,
  author = {Zhao, Baohong},
  title = {Does TNF Promote or Restrain Osteoclastogenesis and Inflammatory Bone Resorption?},
  journal = {Critical Reviews in Immunology},
  year = {2018},
  volume = {38},
  number = {4},
  pages = {253--261},
  doi = {10.1615/critrevimmunol.2018025874}
}
Kostenlos starten →